Filing
Spy
Filing
Spy
Home
About
AKBA — Akebia Therapeutics Inc - FilingSpy
AKBA
Akebia Therapeutics Inc
Biopharmaceutical company
CUSIP: 00972D105
Healthcare
US
2 holders
Ownership
Activity
Fundamentals
2018 Q4
10 of 11 quarters
Total Value
$166.61M
Total Shares
30.13M
Net Share Change
+29.01M
Activity
2 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$135.33M
24.47M
1.2%
NEW
Baupost Group LLC
$135.33M
24.47M shares
NEW
Abrams Capital Management
$31.28M
5.66M
1.3%
ADD
+4.54M
(+405.4%)
Abrams Capital Management
$31.28M
5.66M shares
ADD
+4.54M
(+405.4%)